Page last updated: 2024-10-22

amlodipine and Siderosis

amlodipine has been researched along with Siderosis in 1 studies

Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.

Siderosis: A form of pneumoconiosis resulting from inhalation of iron in the mining dust or welding fumes.

Research Excerpts

ExcerptRelevanceReference
"Our meta-analysis found that amlodipine significantly increases cardiac T2* and decreases MIC, hence decreasing the incidence of cardiomyopathy-related iron overload in thalassemia patients."5.41Efficacy and safety of calcium channel blockers in preventing cardiac siderosis in thalassemia patients: An updated meta-analysis with trial sequential analysis. ( Abdelaziz, A; Abdelwahab, OA; Amer, BE; Badawy, MM; Diab, RA; Elsharkawy, A; Goudy, YM; Mouffokes, A; Soliman, Y, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Soliman, Y1
Abdelaziz, A1
Mouffokes, A1
Amer, BE1
Goudy, YM1
Abdelwahab, OA1
Badawy, MM1
Diab, RA1
Elsharkawy, A1

Reviews

1 review available for amlodipine and Siderosis

ArticleYear
Efficacy and safety of calcium channel blockers in preventing cardiac siderosis in thalassemia patients: An updated meta-analysis with trial sequential analysis.
    European journal of haematology, 2023, Volume: 110, Issue:4

    Topics: Amlodipine; beta-Thalassemia; Calcium Channel Blockers; Humans; Iron; Iron Chelating Agents; Iron Ov

2023